Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1524-2026

GEM Premier 5000 PAK, Part No. 00055360004. Recall

GEM Premier 5000 PAK, Part No. 00055360004.

FDA recall Class II

Ongoing

FDA lists this Class II recall for GEM Premier 5000 PAK, Part No. 00055360004.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1524-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jan 20, 2026
FDA report date
Mar 18, 2026
Quantity in commerce
51 units
Distribution
See key details
FDA cause
Nonconforming Material/Component

What is being recalled?

GEM Premier 5000 PAK, Part No. 00055360004.

Affected model & UDI checker

Search the exact identifiers published for Z-1524-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedGEM Premier 5000 PAK, Part No. 00055360004.Check source notice08426950899662
FDA code information

Part number: 00055360004; UDI: 08426950899662; Lot No. 251113U, 251201AI, 251202Q, 251223E, 251223P, 251229X.

View the original FDA recall notice

Why was this product recalled?

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of a new GEM PAK. iQM2 is an active quality process control program designed to provide continuous monitoring of the entire testing process. Thus, if a GEM PAK completes AutoPAK Validation following warm-up, it may remain in use. Consecutive GEM PAK ejections during warm-up may prolong turnaround times, potentially delaying results. In such cases, patient management may require reassessment once results are available. While many GEM PAKs continue to perform as intended, consecutive ejections may increase the likelihood of operational disruption, highlighting the importance of advance planning where feasible to help minimize impact.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Instrumentation Laboratory take?

An URGENT MEDICAL DEVICE CORRECTION notice was sent to consignees on 1/20/26 was sent to consignees. The notice instructs consignees to continue to use affected devices with the provided warmup instructions. Consignees are to inform all laboratory staff of this notification and forward the notification if product was further distributed. A copy of the notification is to be maintained in consignee records. Consignees may contact Werfen Technical Support at 1-800-678-0710 for a replacement if a GEM PAK experiences a Process Control Solution Not Detected error.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology